Home Industry Reports Custom Research Blogs About Us Contact us

Biologics Contract Development Market Size & Share, By Source (Mammalian, Microbial), Service Type, Indication (Oncology, Immunological Disorders), Regional Forecast, Industry Players, Growth Statistics Report 2024-2032

Report ID: FBI 5849

|

Published Date: Aug-2024

|

Format : PDF, Excel

التوقعات السوقية:

Biologics Contract Development Market was over USD 8.08 Billion in 2023 and is expected to exceed USD 16.42 Billion by end of the year 2032, observing around 8.2% CAGR between 2024 and 2032.

Base Year Value (2023)

USD 8.08 Billion

19-23 x.x %
24-32 x.x %

CAGR (2024-2032)

8.2%

19-23 x.x %
24-32 x.x %

Forecast Year Value (2032)

USD 16.42 Billion

19-23 x.x %
24-32 x.x %
Biologics Contract Development Market

Historical Data Period

2019-2023

Biologics Contract Development Market

Largest Region

North America

Biologics Contract Development Market

Forecast Period

2024-2032

Get more details on this report -

سوق الديناميكية:

Growth Drivers & Opportunity:

Biologics contract development market is expected to witness significant growth due to increasing demand for personalized medicine, advancements in biotechnology, and rising investments in research and development.

Report Scope

Report CoverageDetails
Segments CoveredSource, Service, Indication
Regions Covered• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company ProfiledWuXi Biologics, Abzena, Fujifilm Diosynth Biotechnologies, KBI Biopharma, AGC Biologics, Thermo Fisher Scientific, Curia Global,, Genscript, Bionova Scientific,, BioXcellence, STC Biologics

Unlock insights tailored to your business with our bespoke market research solutions - Click to get your customized report now!

Industry Restraints:

However, the market may face challenges such as stringent regulatory requirements and high costs associated with biologics development and manufacturing.

Growth Drivers & Opportunity:

Furthermore, the growing prevalence of chronic diseases and increasing adoption of biologics for the treatment of various diseases are expected to drive the growth of the market in the coming years.

Report Scope

Report CoverageDetails
Segments CoveredSource, Service, Indication
Regions Covered• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company ProfiledWuXi Biologics, Abzena, Fujifilm Diosynth Biotechnologies, KBI Biopharma, AGC Biologics, Thermo Fisher Scientific, Curia Global,, Genscript, Bionova Scientific,, BioXcellence, STC Biologics

Unlock insights tailored to your business with our bespoke market research solutions - Click to get your customized report now!

Industry Restraints:

The complex manufacturing processes and the need for specialized expertise may act as restraints for the biologics contract development market.

التوقعات الإقليمية:

Biologics Contract Development Market

Largest Region

North America

43% Market Share in 2023

Get more details on this report -

North America:

The Biologics Contract Development market in North America is dominated by the United States, which is one of the largest markets globally. The presence of key players, significant investments in research and development, and favorable government regulations contribute to the growth of the market in the region. Canada also plays a significant role in the North American market, with a growing number of contract development organizations offering biologics services.

Asia Pacific:

In Asia Pacific, China is a key player in the Biologics Contract Development market, with a rapidly expanding biopharmaceutical industry and increasing outsourcing activities. Japan and South Korea also contribute significantly to the market, with advanced infrastructure and technological capabilities supporting the growth of biologics contract development services in the region.

Europe:

Europe is a prominent market for Biologics Contract Development, with countries like the United Kingdom, Germany, and France leading the way. The presence of established contract development organizations, strong regulatory framework, and increasing demand for biologics services drive the growth of the market in Europe. The United Kingdom, in particular, is known for its expertise in biologics development, making it a key player in the European market.

Report Coverage & Deliverables

Historical Statistics Growth Forecasts Latest Trends & Innovations Market Segmentation Regional Opportunities Competitive Landscape
Biologics Contract Development Market
Biologics Contract Development Market

تحليل التجزئة:

""

In terms of segmentation, the global Biologics Contract Development market is analyzed on the basis of Source, Service, Indication.

Mammalian Source:

The biologics contract development market for mammalian source is anticipated to witness significant growth due to the increasing demand for mammalian cell line-based biologics production. Mammalian cells offer several advantages such as high productivity, proper post-translational modifications, and ability to produce complex proteins. These factors are driving the market growth for mammalian source biologics contract development services.

Microbial Source:

The microbial source segment in the biologics contract development market is also expected to show substantial growth. Microbial expression systems, such as bacteria and yeast, are widely used for the production of recombinant proteins. These systems are cost-effective and can produce high yields of proteins in a short period of time. The microbial source segment is likely to experience growth due to the rising demand for microbial-based biologics development services.

Service Type:

The service type segment in the biologics contract development market includes cell line development, process development, analytical services, and others. Cell line development services are crucial for the production of biologics as they involve the selection and generation of stable cell lines for protein expression. Process development services focus on optimizing the bioprocess to enhance productivity and efficiency. Analytical services play a key role in ensuring the quality, safety, and efficacy of biologics. The demand for these services is expected to drive growth in the biologics contract development market.

Indication Oncology:

The oncology indication segment in the biologics contract development market is witnessing significant growth due to the increasing prevalence of cancer worldwide. Biologics play a crucial role in the treatment of various types of cancer by targeting specific molecules involved in cancer growth and progression. The development of biologics for oncology indications requires specialized expertise and services, driving the demand for biologics contract development in this segment.

Indication Immunological Disorders:

The immunological disorders indication segment in the biologics contract development market is also expected to show growth. Biologics are widely used in the treatment of various immunological disorders such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. The development of biologics for immunological disorders involves complex processes and specialized services, creating opportunities for growth in this segment of the biologics contract development market.

Get more details on this report -

مشهد تنافسي:

Top Market Players:

Lonza Group

Boehringer Ingelheim GmbH

Samsung Biologics

WuXi Biologics

Catalent, Inc.

Thermo Fisher Scientific Inc.

Charles River Laboratories International, Inc.

Patheon N.V.

Toxikon Corporation

Evotec AG

The competitive landscape in the Biologics Contract Development Market is fierce and rapidly evolving with numerous companies vying for market share. These companies offer a range of services including cell line development, process development, analytical testing, and manufacturing of biologics for pharmaceutical and biotechnology companies globally. The market is characterized by intense competition, technological advancements, strategic collaborations, and acquisitions to strengthen their market position and expand their service offerings to meet the growing demand for biologics contract development services.

Our Clients

Why Choose Us

Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.

Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.

Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.

Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.

Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.

Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.

Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.

Select Licence Type

Single User

US$ 4250

Multi User

US$ 5050

Corporate User

US$ 6150

Biologics Contract Development Market Size & Share...

RD Code : 24